1329745-98-3 Usage
Description
Citalopram Dimethylaminobutanone, an impurity of Citalopram Hydrobromide Salt (C505000), is a compound that plays a significant role in the pharmaceutical industry. It is derived from Citalopram, a potent selective serotonin reuptake inhibitor (SSRI) that is widely used as an antidepressant. The presence of Citalopram Dimethylaminobutanone in the formulation may affect the overall efficacy and safety of the medication.
Uses
Used in Pharmaceutical Industry:
Citalopram Dimethylaminobutanone is used as an impurity in the production of Citalopram, a potent SSRI antidepressant. Its presence in the final product may impact the overall effectiveness and safety of the medication, making it crucial to monitor and control its levels during the manufacturing process.
Used in Antidepressant Formulations:
Citalopram Dimethylaminobutanone is indirectly involved in the development and formulation of antidepressant medications, specifically those containing Citalopram as the active ingredient. As an impurity, it may affect the overall performance of the drug, emphasizing the importance of quality control and purification processes in the pharmaceutical industry.
Used in Research and Development:
Citalopram Dimethylaminobutanone may also be utilized in research and development efforts to better understand the properties and interactions of Citalopram and its related compounds. This knowledge can contribute to the development of more effective and safer antidepressant medications in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 1329745-98-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,2,9,7,4 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1329745-98:
(9*1)+(8*3)+(7*2)+(6*9)+(5*7)+(4*4)+(3*5)+(2*9)+(1*8)=193
193 % 10 = 3
So 1329745-98-3 is a valid CAS Registry Number.
1329745-98-3Relevant articles and documents
Of escitalopram oxalate-related substance and its preparation method
-
Paragraph 0045; 0046, (2018/12/13)
The invention relates to an escitalopram oxalate related substance and a preparation method thereof, and particularly, relates to the related substance of an antidepressant drug, the escitalopram oxalate (namely, (S)-(+)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-formonitrile oxalate), represented as the formula (I) and a preparation method thereof. The escitalopram oxalate, as the target compound, is synthesized through reactions comprising hydrolysis, acylation, condensation, reduction, addition and oxidization to the compound (II) (namely, (S)-(+)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-formonitrile). According to the method, the compound (I) is chemically synthesized for the first time. By means of the method, the target compound can be obtained through high-efficient and quick separation.
